| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.31e-05 | 14 | 130 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.30e-04 | 171 | 130 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.69e-04 | 125 | 130 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.26e-04 | 46 | 130 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.47e-04 | 86 | 130 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.15e-04 | 5 | 130 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.67e-04 | 151 | 130 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.69e-04 | 103 | 130 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 6.20e-04 | 6 | 130 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 6.20e-04 | 6 | 130 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C GABRP CACNA1D CACNA1E TPCN2 SLC1A4 CLCN6 GLRA2 GLRB SCN4A | 8.54e-04 | 459 | 130 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 1.06e-03 | 31 | 130 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 1.15e-03 | 8 | 130 | 2 | GO:0005237 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.47e-03 | 9 | 130 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.47e-03 | 9 | 130 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.57e-03 | 334 | 130 | 8 | GO:0022836 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2.31e-06 | 5 | 128 | 3 | GO:1904879 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 1.69e-05 | 180 | 128 | 8 | GO:0015698 | |
| Domain | Ca_chan_IQ | 1.08e-05 | 7 | 128 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.08e-05 | 7 | 128 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.08e-05 | 7 | 128 | 3 | IPR014873 | |
| Domain | GPHH | 1.08e-05 | 7 | 128 | 3 | PF16905 | |
| Domain | GPHH_dom | 1.08e-05 | 7 | 128 | 3 | IPR031649 | |
| Domain | VDCCAlpha1 | 3.64e-05 | 10 | 128 | 3 | IPR002077 | |
| Domain | Channel_four-helix_dom | 4.40e-05 | 57 | 128 | 5 | IPR027359 | |
| Domain | - | 4.40e-05 | 57 | 128 | 5 | 1.20.120.350 | |
| Domain | MOZART2 | 4.66e-05 | 2 | 128 | 2 | IPR024332 | |
| Domain | MOZART2 | 4.66e-05 | 2 | 128 | 2 | PF12926 | |
| Domain | CAC1F_C | 1.39e-04 | 3 | 128 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.39e-04 | 3 | 128 | 2 | PF16885 | |
| Domain | RUN | 2.38e-04 | 18 | 128 | 3 | SM00593 | |
| Domain | VDCC_L_a1su | 2.77e-04 | 4 | 128 | 2 | IPR005446 | |
| Domain | RUN | 2.81e-04 | 19 | 128 | 3 | PS50826 | |
| Domain | RUN | 2.81e-04 | 19 | 128 | 3 | PF02759 | |
| Domain | Run_dom | 2.81e-04 | 19 | 128 | 3 | IPR004012 | |
| Domain | ARM-like | 5.52e-04 | 270 | 128 | 8 | IPR011989 | |
| Domain | Ion_trans_dom | 1.13e-03 | 114 | 128 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.13e-03 | 114 | 128 | 5 | PF00520 | |
| Domain | ARM-type_fold | 2.35e-03 | 339 | 128 | 8 | IPR016024 | |
| Domain | MBD | 2.46e-03 | 11 | 128 | 2 | SM00391 | |
| Domain | MBD | 2.46e-03 | 11 | 128 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 2.46e-03 | 11 | 128 | 2 | IPR001739 | |
| Domain | MBD | 2.46e-03 | 11 | 128 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 2.46e-03 | 11 | 128 | 2 | IPR016177 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.62e-03 | 45 | 128 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 3.85e-03 | 46 | 128 | 3 | PF02932 | |
| Domain | uDENN | 4.02e-03 | 14 | 128 | 2 | SM00800 | |
| Domain | Neurotrans-gated_channel_TM | 4.09e-03 | 47 | 128 | 3 | IPR006029 | |
| Domain | - | 4.09e-03 | 47 | 128 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.09e-03 | 47 | 128 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.09e-03 | 47 | 128 | 3 | PS00236 | |
| Domain | Neur_channel | 4.09e-03 | 47 | 128 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.09e-03 | 47 | 128 | 3 | IPR006202 | |
| Domain | - | 4.30e-03 | 222 | 128 | 6 | 1.25.10.10 | |
| Domain | HEAT | 4.34e-03 | 48 | 128 | 3 | PF02985 | |
| Domain | uDENN | 4.62e-03 | 15 | 128 | 2 | PF03456 | |
| Domain | DENN | 5.25e-03 | 16 | 128 | 2 | SM00799 | |
| Domain | DENN | 5.25e-03 | 16 | 128 | 2 | PF02141 | |
| Domain | dDENN | 5.25e-03 | 16 | 128 | 2 | PF03455 | |
| Domain | UDENN | 5.25e-03 | 16 | 128 | 2 | PS50946 | |
| Domain | DDENN | 5.25e-03 | 16 | 128 | 2 | PS50947 | |
| Domain | dDENN | 5.25e-03 | 16 | 128 | 2 | SM00801 | |
| Domain | dDENN_dom | 5.25e-03 | 16 | 128 | 2 | IPR005112 | |
| Domain | uDENN_dom | 5.25e-03 | 16 | 128 | 2 | IPR005113 | |
| Domain | DENN | 5.25e-03 | 16 | 128 | 2 | PS50211 | |
| Domain | DENN_dom | 5.25e-03 | 16 | 128 | 2 | IPR001194 | |
| Domain | Interferon | 5.93e-03 | 17 | 128 | 2 | PF00143 | |
| Domain | INTERFERON_A_B_D | 5.93e-03 | 17 | 128 | 2 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 5.93e-03 | 17 | 128 | 2 | IPR000471 | |
| Domain | IFabd | 5.93e-03 | 17 | 128 | 2 | SM00076 | |
| Pubmed | TANC2 GRIPAP1 LRRN1 RNF213 TBC1D9 UBE4A METTL13 USF3 ALMS1 LTN1 MBD5 PREX1 | 3.66e-07 | 493 | 130 | 12 | 15368895 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 11296258 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 15451373 | ||
| Pubmed | Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. | 1.01e-06 | 6 | 130 | 3 | 17854396 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 12900400 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C SGSM1 TPCN2 AIMP2 LRRN1 DTNB TTC21A HDAC8 RNF213 CHD9 SH3BP4 SLC35F5 USF3 ZNF827 FAM120C SCARB1 DENND5A MBD5 ZMAT1 | 2.92e-06 | 1489 | 130 | 19 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DIS3L2 AIMP2 NCKAP1 COPB1 FASTKD2 IDH3B TRIP12 METTL13 UBA1 DST SERPINB12 LTN1 XRN1 ASPM DDX39A G6PD BTRC ZMYM3 | 3.08e-06 | 1353 | 130 | 18 | 29467282 |
| Pubmed | TANC2 NTAQ1 RNF213 CHD9 IDH3B SIRT5 METTL13 ALMS1 ZNF827 FAM120C CADPS BRD7 LTN1 XRN1 ASPM ZMYM3 | 4.49e-06 | 1116 | 130 | 16 | 31753913 | |
| Pubmed | 9.91e-06 | 130 | 130 | 6 | 12421765 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21054386 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22606311 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24086669 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 1.39e-05 | 2 | 130 | 2 | 26049024 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 1.39e-05 | 2 | 130 | 2 | 16706838 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23761887 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 1.39e-05 | 2 | 130 | 2 | 25292336 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17526649 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 1.39e-05 | 2 | 130 | 2 | 24941892 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29100804 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22826131 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24470632 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15743413 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24760982 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28242615 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24382015 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20014384 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12973680 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 30001160 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21352396 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 1.39e-05 | 2 | 130 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 1.39e-05 | 2 | 130 | 2 | 16267232 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24996399 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24849370 | ||
| Pubmed | Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. | 1.39e-05 | 2 | 130 | 2 | 8071363 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17015854 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24848473 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.87e-05 | 497 | 130 | 10 | 36774506 | |
| Pubmed | 2.25e-05 | 15 | 130 | 3 | 20188150 | ||
| Pubmed | 2.25e-05 | 15 | 130 | 3 | 24453333 | ||
| Pubmed | 3.30e-05 | 326 | 130 | 8 | 17015433 | ||
| Pubmed | MZT Proteins Form Multi-Faceted Structural Modules in the γ-Tubulin Ring Complex. | 4.15e-05 | 3 | 130 | 2 | 32610146 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17767505 | ||
| Pubmed | ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment. | 4.15e-05 | 3 | 130 | 2 | 28273450 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 2173707 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 26831068 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 16260629 | ||
| Pubmed | Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. | 4.15e-05 | 3 | 130 | 2 | 22120009 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 23338940 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 4.15e-05 | 3 | 130 | 2 | 21832054 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 17289261 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 28806393 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 4.15e-05 | 3 | 130 | 2 | 23973784 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 31302118 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 23045342 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 4.15e-05 | 3 | 130 | 2 | 24934288 | |
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 30889214 | ||
| Pubmed | 4.15e-05 | 3 | 130 | 2 | 22623793 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 4.73e-05 | 19 | 130 | 3 | 1708818 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 7.43e-05 | 186 | 130 | 6 | 33637726 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 9051263 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 20937870 | ||
| Pubmed | Odorant receptors govern the formation of a precise topographic map. | 8.28e-05 | 4 | 130 | 2 | 9546391 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 18710471 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 21486797 | ||
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 18363964 | ||
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 8.28e-05 | 4 | 130 | 2 | 17110593 | |
| Pubmed | 8.28e-05 | 4 | 130 | 2 | 21285945 | ||
| Pubmed | Role of HIV-1 Vpu protein for virus spread and pathogenesis. | 1.11e-04 | 25 | 130 | 3 | 18672082 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.17e-04 | 202 | 130 | 6 | 33005030 | |
| Pubmed | 1.24e-04 | 128 | 130 | 5 | 30995482 | ||
| Pubmed | DENND5B RNASEH2B DIS3L2 FAM186B SAR1A UBE4A NBAS UBA1 BRD7 XRN1 ASPM MTBP TMED2 HEATR3 WDR24 | 1.36e-04 | 1327 | 130 | 15 | 32694731 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 24700029 | ||
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 1.38e-04 | 5 | 130 | 2 | 21850450 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 16537705 | ||
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 1.38e-04 | 5 | 130 | 2 | 18721822 | |
| Pubmed | Allelic inactivation regulates olfactory receptor gene expression. | 1.38e-04 | 5 | 130 | 2 | 8087849 | |
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 31663850 | ||
| Pubmed | 1.38e-04 | 5 | 130 | 2 | 12060068 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATR NCKAP1 DTNB IDH3B SAR1A NEK3 DST BRAF IRAK4 REPS2 G6PD BTRC | 1.64e-04 | 910 | 130 | 12 | 36736316 |
| Pubmed | TANC2 COPB1 UGGT1 SIRT5 ARHGEF10L UBA1 FGD1 CSTF2 MZT2B DDX39A PREX1 BTRC | 1.74e-04 | 916 | 130 | 12 | 32203420 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.82e-04 | 139 | 130 | 5 | 16985003 | |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 2.06e-04 | 6 | 130 | 2 | 16029198 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 21224388 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 36928426 | ||
| Pubmed | Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. | 2.06e-04 | 6 | 130 | 2 | 7891186 | |
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 23734214 | ||
| Pubmed | 2.06e-04 | 6 | 130 | 2 | 23756462 | ||
| Pubmed | 2.10e-04 | 225 | 130 | 6 | 12168954 | ||
| Pubmed | 2.34e-04 | 32 | 130 | 3 | 36252997 | ||
| Pubmed | FASTKD2 IDH3B TRIP12 SAR1A NBAS GLG1 TMED2 DDX39A G6PD HEATR3 | 2.67e-04 | 686 | 130 | 10 | 28380382 | |
| Pubmed | 2.68e-04 | 560 | 130 | 9 | 35241646 | ||
| Pubmed | Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. | 2.88e-04 | 7 | 130 | 2 | 24280982 | |
| Pubmed | 2.88e-04 | 7 | 130 | 2 | 11703931 | ||
| Pubmed | 3.06e-04 | 35 | 130 | 3 | 22337587 | ||
| Pubmed | COPB1 ADAM23 CHD9 TRIP12 CBR3 UBE4A DST CADPS OSBPL1A REPS2 MBD4 QKI PREX1 BTRC | 3.34e-04 | 1285 | 130 | 14 | 35914814 | |
| Pubmed | 3.83e-04 | 8 | 130 | 2 | 28330839 | ||
| GeneFamily | Glycine receptors | 2.01e-04 | 5 | 82 | 2 | 868 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.17e-04 | 26 | 82 | 3 | 253 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.09e-03 | 11 | 82 | 2 | 1025 | |
| GeneFamily | EF-hand domain containing | 3.19e-03 | 219 | 82 | 5 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.35e-03 | 66 | 82 | 3 | 722 | |
| ToppCell | RA-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.08e-06 | 115 | 129 | 6 | 0a37816898eaa18ae49d4d936e1a760f089e0ceb | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.08e-06 | 183 | 129 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.59e-06 | 194 | 129 | 7 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-06 | 195 | 129 | 7 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-06 | 200 | 129 | 7 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-06 | 156 | 129 | 6 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.31e-06 | 156 | 129 | 6 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 172 | 129 | 6 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 173 | 129 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.72e-05 | 186 | 129 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.83e-05 | 188 | 129 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-05 | 189 | 129 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 191 | 129 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 191 | 129 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.06e-05 | 192 | 129 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 117 | 129 | 5 | 5a23770806b4612bed4ae6fd716abdec7f7f56c6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.42e-05 | 118 | 129 | 5 | 5f72022f4be3fb7ccec86dc05d37572833028886 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.42e-05 | 118 | 129 | 5 | 053c0986051e36fdc4c48b8067c137b6299b2f1b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 198 | 129 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.52e-05 | 119 | 129 | 5 | 28d6b0e9dda2fe4ca94ae9b95b7261618d0d9877 | |
| ToppCell | Control-NK_activated|Control / Disease condition and Cell class | 2.52e-05 | 119 | 129 | 5 | 0d0bab03d56e269c6e637b0bbeffe9d1491dfc33 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.52e-05 | 119 | 129 | 5 | 0fdd5b093ac20a4bda0f7b623808eb3ad0bf68e2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.59e-05 | 200 | 129 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.59e-05 | 200 | 129 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | GON4L FASTKD2 SLC1A4 SLC35F5 CLCN6 OSBPL1A ATF7IP2 FGD1 LRIF1 | 9.57e-07 | 180 | 130 | 9 | 947_UP |
| Drug | picrotoxin | 9.72e-06 | 181 | 130 | 8 | CID000031304 | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 9.87e-06 | 24 | 130 | 4 | CID000079091 | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 7377_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; PC3; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 4561_UP | |
| Drug | AC1Q3ZOL | 1.79e-05 | 258 | 130 | 9 | CID000002376 | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 5443_DN | |
| Disease | goiter (is_implicated_in) | 1.84e-05 | 2 | 127 | 2 | DOID:12176 (is_implicated_in) | |
| Disease | migraine (implicated_via_orthology) | 1.10e-04 | 4 | 127 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.10e-04 | 4 | 127 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability (is_implicated_in) | 1.82e-04 | 5 | 127 | 2 | DOID:0050776 (is_implicated_in) | |
| Disease | Goiter | 3.81e-04 | 7 | 127 | 2 | C0018021 | |
| Disease | Depression, Bipolar | 3.83e-04 | 79 | 127 | 4 | C0005587 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.01e-04 | 36 | 127 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | kynurenine measurement | 6.35e-04 | 39 | 127 | 3 | EFO_0008529 | |
| Disease | N-acetylkynurenine (2) measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0800083 | |
| Disease | N-acetylleucine measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0800116 | |
| Disease | amino acid measurement | TANC2 LRRN1 FASTKD2 SLC1A4 NBAS NEK3 ALMS1 SCN4A STAU2 ATF7IP2 | 7.22e-04 | 678 | 127 | 10 | EFO_0005134 |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 8.09e-04 | 10 | 127 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | anti-topoisomerase-I-antibody-positive systemic scleroderma | 8.09e-04 | 10 | 127 | 2 | EFO_0008537 | |
| Disease | Anxiety States, Neurotic | 9.06e-04 | 44 | 127 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 9.06e-04 | 44 | 127 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 9.06e-04 | 44 | 127 | 3 | C0003469 | |
| Disease | N-delta-acetylornithine measurement | 1.18e-03 | 12 | 127 | 2 | EFO_0800067 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.24e-03 | 49 | 127 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | ovary epithelial cancer (is_marker_for) | 1.39e-03 | 13 | 127 | 2 | DOID:2152 (is_marker_for) | |
| Disease | episodic memory | 1.48e-03 | 52 | 127 | 3 | EFO_0004333 | |
| Disease | Benign neoplasm of stomach | 2.40e-03 | 17 | 127 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.40e-03 | 17 | 127 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.40e-03 | 17 | 127 | 2 | C0154060 | |
| Disease | susceptibility to hepatitis B infection measurement | 2.68e-03 | 64 | 127 | 3 | EFO_0008405 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.00e-03 | 19 | 127 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Manic Disorder | 3.60e-03 | 71 | 127 | 3 | C0024713 | |
| Disease | Stomach Carcinoma | 3.66e-03 | 21 | 127 | 2 | C0699791 | |
| Disease | lung cancer (is_implicated_in) | 4.04e-03 | 74 | 127 | 3 | DOID:1324 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSKAQCIVANEAMAP | 156 | Q6P461 | |
| VRSNCPKAMKRLMAE | 681 | P15056 | |
| LMEMEPKALSARKCQ | 346 | Q9HCE6 | |
| NPSDKQVQVCMRMLK | 96 | P55773 | |
| PSMMCLDRKCLQIQA | 716 | O75077 | |
| CPSKVAYKRLVLMNM | 1781 | Q15878 | |
| KLMCTNAMIYNKPET | 201 | Q9NPI1 | |
| LTPHEKQCMMFSATL | 216 | O00148 | |
| AVLQEKALKFMCSMP | 6 | Q9Y297 | |
| LMEAENMALKRCNFP | 2266 | Q8TCU4 | |
| MCRMSFKKETPLANA | 1 | Q8N6D5 | |
| QTMMCNFLPTAIKFH | 2691 | Q96DT5 | |
| EKNMKCLTFFLMLPE | 6 | Q9Y2F9 | |
| LNPKANREKMTQIMF | 111 | P63267 | |
| MMPFQKNITEKARAL | 756 | Q9NU02 | |
| RECLSSMVTMFPKLQ | 776 | Q8IYM0 | |
| FELMKQMKLCVQNSP | 141 | P33240 | |
| ARKEVLTNMCSRPMQ | 656 | Q8IYB7 | |
| TCLSSDMFMKDNSQP | 336 | Q8IZT6 | |
| GKTALMCKLAEQMPR | 346 | Q149M9 | |
| LPSMCCQKIMQRAIK | 591 | Q6ZP01 | |
| LMNDKKLMSSLPNFC | 21 | Q96PU8 | |
| QMLCLVAMEKPASTN | 266 | P11413 | |
| TSFQNAMLKPMCETL | 1336 | O94822 | |
| PQSICTMFNVMVDAK | 1131 | Q9ULU8 | |
| MAQMRRISPFSCLKD | 41 | P01570 | |
| KSVFSNSSKEMMCFP | 56 | P31513 | |
| RSKNMPIKDNALVMF | 346 | Q5T3J3 | |
| LMQKGQQMLARCPKS | 6546 | Q03001 | |
| MLIPFSMKNCFQLLC | 1 | Q9Y234 | |
| QKNKDTAPMDNTFLM | 836 | Q5T655 | |
| STPDCKNMMSTLEIN | 5451 | Q5CZC0 | |
| QCSNMQPKLMLRRTE | 1116 | O60486 | |
| DLMLVCTNVPKMAAN | 71 | Q96R30 | |
| ISFMQLTAKNEMNCK | 671 | P53618 | |
| MAQMGRISPFSCLKD | 41 | P01569 | |
| DLTLFPMDTQRCKMQ | 186 | P48167 | |
| PMDTQRCKMQLESFG | 191 | P48167 | |
| MMDLRNTPAKSLDKF | 1 | P00973 | |
| ECDMAKEMLPSFLQK | 386 | Q9BXW6 | |
| LKMCRSLYNTKQMLP | 2221 | A2RRP1 | |
| SNQMFAMKEIRLPKS | 26 | P51956 | |
| LSLCNMFLDEMAKQA | 596 | Q9Y2A7 | |
| QMIKRFCPEADSKTM | 886 | Q92896 | |
| MIDDSMICAGNLQKP | 486 | Q14520 | |
| MTGKELRQCMLPKSA | 2401 | Q13535 | |
| PNLVNTMMELRKCCN | 1131 | Q3L8U1 | |
| QSMKSYPSSELRNMC | 676 | P51797 | |
| MASKNISQCMTPDQL | 526 | Q7Z4Q2 | |
| PKIKFETMIIDNCCM | 241 | O43837 | |
| EKNLFPSNCLGMMLL | 141 | Q9H0H3 | |
| FMMIALPNMNKSFTC | 221 | O15229 | |
| VACKRLVSMNMPLNS | 1586 | Q13936 | |
| LRNMPYLKACLKESM | 371 | Q07973 | |
| ESNANPIFMRKDTKM | 86 | Q9BVM2 | |
| AFLACMKSDTPSMLN | 741 | Q9NX05 | |
| KFQTLFQPCNLMGAM | 746 | Q3T8J9 | |
| AVNMLCMPKGLSFRT | 76 | Q6ZUT9 | |
| MQIPKNLLEMTFECQ | 971 | Q6ZUT9 | |
| TCFPQQRKIMLNMFL | 196 | O60941 | |
| TPMSFMKACRSVLEQ | 211 | Q6IQ26 | |
| KTMPLSCRKQVEMLN | 16 | Q5U623 | |
| EQMMIKRSSECNPLL | 51 | O95243 | |
| LKNFPMDVQTCTMQL | 176 | P23416 | |
| KSPVMKKPMCNFSTN | 306 | Q9P267 | |
| KKPMCNFSTNMEIPR | 311 | Q9P267 | |
| FATRNMCNELLPIMK | 116 | O75828 | |
| ACLDMMPKSFKFLPQ | 381 | Q9BZJ6 | |
| QQKQMPFCDKDRTLM | 121 | Q9NWZ3 | |
| SMCDSLAKIPKRASM | 26 | Q9BY41 | |
| QMKECNATRRPQMSF | 86 | Q8N6R0 | |
| LMAEFSKLCSQMEQL | 96 | Q4V328 | |
| CNSNKLKEMAQSIFM | 116 | Q8TCC7 | |
| DPNNQIICKMASMLS | 141 | Q9P1A2 | |
| VACKRLVAMNMPLNS | 1526 | Q01668 | |
| SKMNLNDFISMDPKV | 171 | Q96HA8 | |
| NMDLSKYPMDTQTCK | 161 | O00591 | |
| KTNIRFMEPLSMFCA | 386 | Q6UXK5 | |
| VQMIKLSDLPSCYMS | 306 | Q96DY7 | |
| MNQFRMLFSTCKVPG | 156 | Q9UKG9 | |
| LCFSSVTMPKLLQNM | 71 | P47887 | |
| LCFSSVTMPKLLQNM | 71 | Q8WZA6 | |
| PLSIIADMCMQKVQF | 436 | Q8WV83 | |
| ALKQTMEEKFMAANP | 1696 | P35499 | |
| AMLSMVKYNSCADRP | 206 | Q9UKY4 | |
| MTNCSNMSLRKVPAD | 31 | Q9BXR5 | |
| LSRPQDLKVCMFSNM | 531 | Q9P0V3 | |
| FLSCTMMPNFKELIH | 511 | A0AVI2 | |
| PAFNQLCEHMMREAK | 211 | Q9NYY8 | |
| KEVTMCMRCQEPFNS | 731 | P98174 | |
| KCIMQATDIMRKQGP | 1611 | Q8TCU6 | |
| PMNCSVKLQLSLYMK | 381 | Q8WTV0 | |
| KELNARPMEVFMCSV | 166 | Q9NR31 | |
| CNMKFPTQSSFDRVM | 691 | Q9HCD6 | |
| FCLNANENKSVKMMT | 211 | Q96P63 | |
| MKMHFCIPVSQQRSD | 1 | Q8N9S9 | |
| LFTDLSCNPEMMKNA | 46 | Q5VW32 | |
| PVRQNGKCMAKMILS | 191 | P34969 | |
| NVPKTQMKFSIQTMC | 191 | Q13155 | |
| FMDIKNKMAQDSLPS | 4991 | Q63HN8 | |
| KCELPLPRFMMSKND | 131 | Q8NFH8 | |
| MANPKEKTAMCLVNE | 1 | Q9NUL3 | |
| MKNGLMFVKLVNPCS | 31 | Q5TBB1 | |
| ANLKGMFMQLCDIPR | 456 | O43511 | |
| TPGRCFMKKTIDMLQ | 146 | P23942 | |
| SATLPSMMKCIEENN | 346 | P43007 | |
| DKPVCMMARITSAKN | 1231 | Q6ZT07 | |
| SFLRMPQTMTVCQVK | 1461 | Q8IZH2 | |
| SICNKPSYQKMPLFM | 136 | Q9HBJ7 | |
| MNTVACLPNMKSKRL | 781 | Q68DE3 | |
| CFTELMKRMNQNFPH | 1001 | Q2NKQ1 | |
| NMLRNILPKQSCYME | 681 | Q8NDW8 | |
| AQEVMKACSGKFMPI | 406 | P22314 | |
| EKMAMFSLACILPFK | 96 | P57060 | |
| PCSQIKLQMDALTSM | 1176 | Q8IUG5 | |
| KFCFSNRMSTMTPKI | 91 | Q15363 | |
| DFLMKLSAANQKEPM | 576 | Q17R98 | |
| SRKKPMLSACNSMMF | 26 | A8MUI8 | |
| TKTAMTEPQMLQNCL | 571 | Q14139 | |
| SCGLPLMNSFNLKDM | 476 | Q96S15 | |
| LMKCINDPNSMFLTG | 1406 | O15050 | |
| RNQICLKMARPSSSM | 26 | Q9NXA8 | |
| KMNNCLSQMEQFPVK | 1221 | Q14669 | |
| RNMKMKDCLDFTPSV | 181 | Q6ZP80 | |
| EDSQCLMMQKFEKVP | 1561 | P01266 | |
| MSKACTNDDQMKTPL | 481 | Q8NA31 | |
| KAAMCKPLMQNRGVS | 831 | Q14202 | |
| KPLMQNRGVSCKVEM | 836 | Q14202 | |
| RPFFLLQNSSMMKKT | 191 | Q8NHX9 | |
| MNLRVFMNCQSKLSD | 1016 | Q9NYU2 | |
| FMNCQSKLSDMPLKS | 1021 | Q9NYU2 | |
| KFCDLCNMMFSSPLI | 121 | Q5H9K5 | |
| QEGCFMIAPQKMRLS | 1321 | Q9P2D8 | |
| MIAPQKMRLSTCFNA | 1326 | Q9P2D8 | |
| LKSNEMLFSMCQVPL | 356 | Q86W24 | |
| NVAPLAVFQMLKSMC | 66 | Q6P582 | |
| NVAPLAVFQMLKSMC | 66 | Q6NZ67 |